ATM |
Ataxia–telangiectasia mutated kinase |
BLBCs |
Basal-like breast cancer cells |
β-TrCP |
Beta-transducin repeat-containing protein |
CBP |
CREB-binding protein |
CDK2 |
Cyclin-dependent kinase 2 |
CSN5 |
COP9 signalosome subunit 5 |
CtBP |
C-terminal binding protein |
CZF |
C-terminal zinc finger |
DUBs |
Deubiquitinating enzymes |
ECM |
Extracellular matrix |
EMT |
Epithelial–mesenchymal transition |
EMT-TFs |
EMT-transcription factors |
EndoMT |
Endothelial-to-mesenchymal transition |
ERK |
Extracellular signal-regulated kinases |
FBXL14 |
F-Box and leucine-rich repeat protein 14 |
FBXL5 |
F-box and leucine-rich repeat protein 5 |
FBXO11 |
F-box only protein 11 |
FBXO45 |
F-box only protein 45 |
FBXW7 |
F-box/WD repeat-containing protein 7 |
GSK3β |
Glycogen synthase kinase 3 |
HAT |
Histone acetyltransferase |
HCC |
Hepatocellular carcinoma |
HDAC1/2 |
Histone deacetylase 1/2 |
HNSCC |
Head and neck squamous cell carcinoma |
IGF-1 |
Insulin-like growth factor-1 |
IL-6 |
Interleukin 6 |
Lats2 |
Large tumor suppressor kinase 2 |
MAPK |
Mitogen-activated protein kinase |
MDM2 |
Mouse double minute 2 homolog |
MET |
Mesenchymal–epithelial transition |
MMPs |
Matrix metalloproteinases |
NF-κB |
Nuclear factor-kappa B |
NSCLC |
Non-small cell lung cancer |
NuRD |
Nucleosome remodeling and deacetylation |
NZF |
N-terminal zinc finger |
O-GlcNAc |
O-linked β-N-acetylglucosamine |
Pc2 |
Polycomb protein 2 |
PCAF |
p300/CBP-associated factor |
PI3K |
Phosphoinositide 3-kinase |
PKA |
Protein kinase A |
PKC |
Protein kinase C |
PKCα |
Protein kinase C alpha |
PKD1 |
Protein kinase D1 |
PRMTs |
Protein arginine methyl transferases |
PTM |
Post-translational modification |
SBD |
SMAD-binding domain |
SCP |
Small C-terminal domain phosphatase |
SRD |
Serine-rich domain |
TGF-β |
Transforming growth factor beta |
Tip60 |
Tat-interacting protein of 60 kDa |
USP51 |
Ubiquitin specific peptidase 51 |
ZnF |
Zinc finger |